Xeris Biopharma Holdings, Inc. (XERS) › Capital ExpendituresXeris Biopharma Holdings, Inc. (XERS) — Capital ExpendituresAnnual figures by period end, from SEC filings.2020-12-31: $377.0K2021-12-31: $1.08M$1.08M2020-12-31Capital Expenditures (USD)2021-12-31Period endedCapital ExpendituresChange YoYSource filing2021-12-31$1.08M+187.8%2022-03-11From 2021-01-012020-12-31$377.0K—2022-03-11From 2020-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)